Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MGLL | Q99685 | 9/20 | 0.49 |
| ▸ | FAAH | O00519 | 4/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29354362 | 1.00 | MAPK1 (0.54) | MAPK1KMT2AMGLLFAAHALDH1A1 | |
| Succinic Acid SCHEMBL28454817 | 0.93 | MAPK1 (0.51) | MAPK1KMT2AMGLLFAAHALDH1A1 | |
| SCHEMBL28297910 | 0.88 | MGLL (0.55) | MAPK1KMT2AMGLLFAAHALDH1A1 | |
| SCHEMBL10328160 | 0.85 | NSD2 (0.49) | MAPK1KMT2AMGLLFAAHALDH1A1 | |
| SCHEMBL10328161 | 0.85 | NSD2 (0.53) | MAPK1KMT2AMGLLFAAHALDH1A1 | |
| SCHEMBL28626188 | 0.85 | MAPK1 (0.46) | MAPK1KMT2AMGLLFAAHALDH1A1 | |
| SCHEMBL15991691 | 0.85 | MAPK1 (0.46) | MAPK1KMT2AMGLLFAAHALDH1A1 | |
| SCHEMBL15337086 | 0.85 | MGLL (0.47) | MAPK1KMT2AMGLLFAAHALDH1A1 | |
| SCHEMBL15991845 | 0.84 | MAPK1 (0.45) | MAPK1KMT2AMGLLFAAHALDH1A1 | |
| SCHEMBL14860981 | 0.83 | MAPK1 (0.48) | MAPK1KMT2AMGLLALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2020 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747409-A2 | COLLECTION, ASSESSMENT AND EARLY DETECTION OF HUMAN LUNG CANCER BIOMARKERS IN EXHALED BREATH CONDENSATES OF MOUSE ANIMAL MODELS | Hackensack Meridian Health, Inc. (US) | 2026-05-27 | — | — | EP | claimed |
| US-20260092317-A1 | TETHERED AMPLIFICATION PRODUCTS IN CELLS AND TISSUES | SINGULAR GENOMICS SYSTEMS INC (US) | 2026-04-02 | — | — | US | claimed |
| EP-4676543-A1 | METHODS OF TREATING CANCER USING ANTI-HER2 ANTIBODY-DRUG CONJUGATES AND HER2 KINASE INHIBITORS | Seagen Inc. (US) | 2026-01-14 | — | — | EP | claimed |
| WO-2025100169-A1 | STAIN TEST CONTROL SUBSTANCE, STAIN TEST SLIDE GLASS PREPARED USING SAME, STAIN TEST CONTROL SUBSTANCE PREPARATION KIT, AND METHOD FOR PRODUCING STAIN TEST CONTROL SUBSTANCE | 株式会社日立ハイテク | 2025-05-15 | — | — | WO | claimed |
| WO-2025055589-A1 | METHODS OF TREATING CERVICAL CANCER USING ANTI-HER2 ANTIBODY-DRUG CONJUGATES | REMEGEN CO., LTD. (CN) | 2025-03-20 | — | — | WO | claimed |
| WO-2025054918-A1 | METHODS OF TREATING CANCER USING ANTI-HER2 ANTIBODY-DRUG CONJUGATES AND ANTI-PD-1 ANTIBODIES | REMEGEN CO., LTD. (CN) | 2025-03-20 | — | — | WO | claimed |
| WO-2025054916-A1 | METHODS OF TREATING CERVICAL CANCER USING ANTI-HER2 ANTIBODY-DRUG CONJUGATES | REMEGEN CO., LTD. (CN) | 2025-03-20 | — | — | WO | claimed |
| WO-2025055598-A1 | METHODS OF TREATING CANCER USING ANTI-HER2 ANTIBODY-DRUG CONJUGATES AND ANTI-PD-1 ANTIBODIES | REMEGEN CO., LTD. (CN) | 2025-03-20 | — | — | WO | claimed |
| WO-2025038638-A1 | METHODS OF TREATING CANCER USING ANTI-HER2 ANTIBODY-DRUG CONJUGATES | SEAGEN INC. (US) | 2025-02-20 | — | — | WO | claimed |
| WO-2025019709-A2 | COLLECTION, ASSESSMENT AND EARLY DETECTION OF HUMAN LUNG CANCER BIOMARKERS IN EXHALED BREATH CONDENSATES OF MOUSE ANIMAL MODELS | HACKENSACK MERIDIAN HEALTH, INC. (US) | 2025-01-23 | — | — | WO | claimed |
| EP-0959905-B1 | POLYSACCHARIDE-PEPTIDE-CONJUGATES | SANOFI PASTEUR (FR) | 2009-12-09 | — | — | EP | claimed |
| EP-2073011-A1 | Means and methods of processing biological samples | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2009-06-24 | — | — | EP | claimed |
| US-20030138975-A1 | Diagnostic signal amplification with proteinoid microspheres | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-07-24 | — | — | US | claimed |
| WO-2003054546-A2 | DIAGNOSTIC SIGNAL AMPLIFICATION WITH PROTEINOID MICROSPHERES | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2003-07-03 | — | — | WO | claimed |
| EP-0649857-A1 | Peptide having inflammation affinity and radioactive diagnostic containing the same | NIHON MEDI-PHYSICS Co., Ltd. (JP) | 1995-04-26 | — | — | EP | claimed |
| EP-0227351-B1 | IMMOBILIZED C-PEPTIDE ANTIBODY, AND THE PREPARATION AND USE THEREOF | SHIONOGI & CO., LTD. (JP) | 1991-11-13 | — | — | EP | claimed |
| US-4443365-A | Method for determination of the valproic acid and reagents therein | DAINIPPON PHARMACEUTICAL COMPANY LIMITED (JP) | 1984-04-17 | — | — | US | claimed |
| US-4400376-A | Immunological preparations | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1983-08-23 | — | — | US | claimed |
| EP-0031812-B1 | IMPROVEMENTS IN OR RELATING TO IMMUNOLOGICAL PREPARATIONS | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1983-06-15 | — | — | EP | claimed |
| EP-0006916-B1 | IMMUNOLOGICAL PREPARATIONS INCORPORATING MHC ANTIGENS AND THEIR PRODUCTION | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1981-07-08 | — | — | EP | claimed |